Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 25;2(1):pky007.
doi: 10.1093/jncics/pky007. eCollection 2018 Jan.

Racial Disparities in Time From Diagnosis to Treatment for Stage I Non-Small Cell Lung Cancer

Jordan A Holmes  1 , Ronald C Chen  1   2   3
Affiliations

Racial Disparities in Time From Diagnosis to Treatment for Stage I Non-Small Cell Lung Cancer

Jordan A Holmes et al. JNCI Cancer Spectr. .

Abstract

Background: Delay in lung cancer treatment is associated with worse survival outcomes. We examined whether there are racial disparities in time from diagnosis to treatment initiation for stage I non-small cell lung cancer (NSCLC) using data from the National Cancer Data Base, which includes approximately 70% of incident cancer patients across the United States.

Methods: We analyzed 119 184 patients diagnosed with stage I NSCLC from 2008 to 2013. Median times (in days) from diagnosis to treatment initiation for external beam radiation (EBRT), stereotactic body radiotherapy (SBRT), and surgery (inclusive of wedge resection, lobectomy, and pneumonectomy) were calculated separately and compared among white vs African American (AA) patients using the Wilcoxon rank-sum test. Multivariable linear regression assessed racial differences in days to treatment while adjusting for sex, age, insurance status, regional income, Charlson-Deyo comorbidity score, region, facility type, and treatment. Statistical tests were two-sided.

Results: AA patients had a statistically significantly longer median time to treatment for all three treatment modalities: EBRT 54 days (AA) vs 48 days (white, P < .001); SBRT 66 days vs 55 days (P < .001); surgery 31 vs 26 days (P < .001). In addition, 34% AA vs 24% white patients (P ≤ .001) had treatment initiation eight or more weeks after diagnosis. In multivariable analysis, AA patients experienced an average 8.2-day delay compared with white patients (P < .001).

Conclusions: These results shed light on one possible mechanism of the observed racial disparity in mortality outcomes in NSCLC. Future studies are needed to determine if interventions to reduce treatment delays can reduce racial disparities in this disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of time from diagnosis to treatment in days for white (A) and African American (B) patients. Vertical lines represent median time to treatment.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. - PubMed
    1. Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ.. Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol. 2016;11(10):1672–1681. - PubMed
    1. Hunt B, Balachandran B.. Black:white disparities in lung cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 2015;39(6):908–916. - PubMed
    1. DeSantis CE, Siegel RL, Sauer AG et al. , Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66(4):290–308. - PubMed
    1. Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH.. Racial disparities in the use of SBRT for treating early-stage lung cancer. Lung Cancer (Amsterdam, Netherlands). 2015;89(2):133–138. - PubMed

LinkOut - more resources